For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250321:nRSU7312Ba&default-theme=true
RNS Number : 7312B One Health Group PLC 21 March 2025
21 March 2025
One Health Group plc
("One Health" or the "Company")
PDMR/PCA Dealings
One Health Group plc (AQSE: OHGR), a provider of NHS-funded medical
procedures, announces that further to the announcement on 19 February 2025
regarding the Capital Raising, Derek Bickerstaff, Non-Executive Chairman of
One Health, has notified the Company that he has sold 450,000 ordinary shares
of 0.5 pence each in the Company ("Ordinary Shares") pursuant to the Placing.
Shantanu Shahane, Chief Medical Officer of One Health, has also notified the
Company that he has sold 25,000 Ordinary Shares pursuant to the Placing and
Angela Shahane, a person closely associated to Shantanu Shahane, has notified
the Company that she has sold 35,000 Ordinary Shares pursuant to the Placing.
Furthermore, One Health Group Trustees LLP, the trustee of the One Health
Group Employee Benefit Trust and a person closely associated with Derek
Bickerstaff and Adam Binns, Chief Executive Officer, has notified the Company
that it has sold 684,721 Ordinary Shares pursuant to the Placing.
Additionally, Anthony Nicholas Parker, a Non-Executive Director of One Health,
has notified the Company that he has, indirectly, subscribed for 27,777
Ordinary Shares pursuant to the Placing at the Issue Price for an aggregate
amount of approximately £50,000.
Further details of the Ordinary Shares sold by Mr Bickerstaff, Mr Shahane,
Mrs Shahane and One Health Group Trustees LLP and of the Ordinary Shares
indirectly subscribed by Mr Parker pursuant to the Placing are set out below.
For more information, please contact:
One Health Group plc via Square1 Consulting
Derek Bickerstaff, Chairman
Adam Binns, CEO
Panmure Liberum (Nominated Adviser and Broker) Tel: +44 (0) 20 3100 2000
Emma Earl, Will Goode, Mark Rogers, Joshua Borlant
Rupert Dearden
Square1 Consulting Tel: +44 207 929 5599
David Bick +44 7831 381201
Further information on the Company can be found on its website at
www.onehealth.co.uk (http://www.onehealth.co.uk) .
This announcement should be read in its entirety. In particular, the
information in the "Important Notices" section of the announcement should be
read and understood.
About One Health Group plc
One Health engages over 70 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and in the year to
March 2024 provided much needed care to 13,266 new patients, through almost
34,000 consultations and over 6,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.
One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. One Health has also sought to expand geographically from its
Head Office in Sheffield into neighbouring counties which meet these criteria.
Currently, the Company's activities are focused in Yorkshire, Lincolnshire,
Derbyshire, Nottinghamshire and Leicestershire. Revenue of over £23 million
in the year to 31 March 2024 was derived from over 60 NHS commissioning bodies
in addition to contracts with local NHS Hospital Trusts to transfer their
internal waiting list patients to One Health for quicker treatment.
One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology. The split of inpatient
procedures in the year to 31 March 2024 was as follows: orthopaedics 46% spine
22% general surgery 22% gynaecology 10%.
Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.
*(https://www.onehealth.co.uk/investors
(https://www.onehealth.co.uk/investors) )
The Directors of One Health Group plc accept responsibility for the contents
of this announcement
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Shantanu Shahane
2. Reason for the notification
a) Position/status: Chief Medical Officer
b Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name: One Health Group plc
b) LEI: 984500DC689F5BAD8732
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of £0.005 each
Identification code:
ISIN Code: GB00BNNT0595
b) Nature of the transaction: Sale of shares
c) Price(s) and Volume (s): Sale price(s). £1.80
Volume(s): 25,000
d) Aggregated Information: N/A
Aggregated volume:
Price:
e) Date of the transaction: 20 March 2025
f) Place of the transaction London Stock Exchange (AIM)
1. Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Angela Shahane
2. Reason for the notification
a) Position/status: Person closely associated with Shantanu Shahane, Chief Medical Officer
b Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name: One Health Group plc
b) LEI: 984500DC689F5BAD8732
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of £0.005 each
Identification code:
ISIN Code: GB00BNNT0595
b) Nature of the transaction: Sale of shares
c) Price(s) and Volume (s): Purchase price(s). £1.80
Volume(s): 35,000
d) Aggregated Information: N/A
Aggregated volume:
Price:
e) Date of the transaction: 20 March 2025
f) Place of the transaction London Stock Exchange (AIM)
1. Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Derek Bickerstaff
2. Reason for the notification
a) Position/status: Non-Executive Chairman
b Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name: One Health Group plc
b) LEI: 984500DC689F5BAD8732
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of £0.005 each
Identification code:
ISIN Code: GB00BNNT0595
b) Nature of the transaction: Sale of shares
c) Price(s) and Volume (s): Sale price(s). £1.80
Volume(s): 450,000
d) Aggregated Information: N/A
Aggregated volume:
Price:
e) Date of the transaction: 20 March 2025
f) Place of the transaction London Stock Exchange (AIM)
1. Details of the person discharging managerial responsibilities/person closely
associated
a) Name: One Health Group Trustees LLP
2. Reason for the notification
a) Position/status: Person closely associated with Derek Bickerstaff, Non-Executive Chairman and
Adam Binns, Chief Executive
b Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name: One Health Group plc
b) LEI: 984500DC689F5BAD8732
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of £0.005 each
Identification code:
ISIN Code: GB00BNNT0595
b) Nature of the transaction: Sale of shares
c) Price(s) and Volume (s): Purchase price(s). £1.80
Volume(s): 684,721
d) Aggregated Information: N/A
Aggregated volume:
Price:
e) Date of the transaction: 20 March 2025
f) Place of the transaction London Stock Exchange (AIM)
1. Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Anthony Nicholas Parker
2. Reason for the notification
a) Position/status: Non-Executive Director
b Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name: One Health Group plc
b) LEI: 984500DC689F5BAD8732
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of £0.005 each
Identification code:
ISIN Code: GB00BNNT0595
b) Nature of the transaction: Purchase of shares
c) Price(s) and Volume (s): Purchase price(s). £1.80
Volume(s): 27,777
d) Aggregated Information: N/A
Aggregated volume:
Price:
e) Date of the transaction: 20 March 2025
f) Place of the transaction London Stock Exchange (AIM)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBSGDXDUDDGUB